Catalyst Wire Dossier Catalyst Wire Dossier

Autologous CD8+ T-cells expressing an anti-BCMA CAR

· Cartesian Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous CD8+ T-cells expressing an anti-BCMA CAR, covering 2024-07-01 to 2024-07-01. Get the full timeline:

Most recent: Clinical Trial Update: Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma [Phase 1]

See pricing